Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Filipe L.F. Carvalho"'
Autor:
Kareem N. Rayn, Graham R. Hale, Jonathan B. Bloom, Samuel A. Gold, Filipe L.F. Carvalho, Sherif Mehralivand, Marcin Czarniecki, Bradford J. Wood, Maria J. Merino, Peter Choyke, Barış Türkbey, Peter A. Pinto, Piyush K. Agarwal
Publikováno v:
Diagnostic and Interventional Radiology, Vol 24, Iss 5, Pp 316-320 (2018)
PURPOSE:In the era of multiparametric magnetic resonance imaging (mpMRI) of the prostate gland, incidental findings are occasionally discovered on imaging. We aimed to report our experience of detecting incidental bladder cancers on mpMRI of the pros
Externí odkaz:
https://doaj.org/article/5fc84211a9d74e6689f750b9b0f2db2b
Publikováno v:
European Urology. 82:e141-e142
Autor:
Kendrick Yim, Kevin Melnick, Sarah L. Mott, Vani Gupta, Timothy N. Clinton, Filipe L.F. Carvalho, Matthew Mossanen, Graeme S. Steele, Kent Mouw, Michael A. O'Donnell, Mark A. Preston
Publikováno v:
Journal of Urology. 207
Autor:
Lambros Stamatakis, Jillian Egan, Chaoyi Zheng, Jonathan Hwang, Filipe L.F. Carvalho, Colleen Hamm Kelly, John H. Lynch, Ross Krasnow, Keith J. Kowalczyk, Alexander Zeymo
Publikováno v:
Investigative and Clinical Urology
Investigative and Clinical Urology, Vol 61, Iss 4, Pp 390-396 (2020)
Investigative and Clinical Urology, Vol 61, Iss 4, Pp 390-396 (2020)
Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is standard of care for muscle-invasive bladder cancer (MIBC). However, NAC is used in less than 20% of patients with MIBC. Our goal is to investigate factors
Autor:
Mark A. Preston, Dory Freeman, Adam S. Kibel, Vinayak Muralidhar, Guru Sonpavde, Catherine Curran, Filipe L.F. Carvalho, Sybil T. Sha, Eliezer M. Van Allen, Matthew Mossanen, Kent W. Mouw
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Radiation associated muscle-invasive bladder cancer (RA-MIBC) is a potentially lethal late toxicity following definitive radiation for prostate cancer. RA-MIBC can be dif...
Autor:
Filipe L.F. Carvalho, Ye Wang, Christopher P. Dall, Madhur Nayan, Wesley H. Chou, Bradley McGregor, Matthias F. Stopfkuchen-Evans, Lambros Stamatakis, Mark A. Preston, Adam S. Kibel, Steven L. Chang, Matthew Mossanen
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:382.e7-382.e13
The impact of anemia in postoperative complications following radical cystectomy (RC) is not completely elucidated and its association with direct hospital costs has not been characterized in depth. Our goal is to determine the association between an
Autor:
Filipe L.F. Carvalho, Collier Wright, John H. Lynch, Harry Lee, Sarah A. Holzman, John O’Neill, Nathan Shaw, Jillian Egan, Keith J. Kowalczyk, Kenneth Witmer
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) is reported to improve urinary functional outcomes faster over standard RARP. However, there are reports of...
Autor:
Christopher Dall, Filipe L.F. Carvalho, Nathan Shaw, Ross Krasnow, Jilian Egan, Lambros Stamatakis
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Extended outpatient chemoprophylaxis (ECP) following radical cystectomy (RC) for bladder cancer is proven to reduce rates of venous thromboembolism (VTE). While ECP is co...
Autor:
Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, Nebiyou Y. Metaferia, Jiao Li, Shatha AbuHammad, Stephen Tang, Thomas Denize, Emma R. Garner, Xin Gao, David A. Braun, Laure Hirsch, John A. Steinharter, Gabrielle Bouchard, Emily Walton, Destiny West, Chris Labaki, Shaan Dudani, Chun-Loo Gan, Vidyalakshmi Sethunath, Filipe L.F. Carvalho, Alma Imamovic, Cora Ricker, Natalie I. Vokes, Jackson Nyman, Jacob E. Berchuck, Jihye Park, Michelle S. Hirsch, Rizwan Haq, Gwo-Shu Mary Lee, Bradley A. McGregor, Steven L. Chang, Adam S. Feldman, Catherine J. Wu, David F. McDermott, Daniel Y.C. Heng, Sabina Signoretti, Eliezer M. Van Allen, Toni K. Choueiri, Srinivas R. Viswanathan
Publikováno v:
Cell Rep
Translocation renal cell carcinoma (tRCC) is a poorly-characterized subtype of kidney cancer driven by MiT/TFE gene fusions. Here, we define the landmarks of tRCC through an integrative analysis of 152 patients with tRCC identified across genomic, cl
Publikováno v:
Urology Case Reports
Urology Case Reports, Vol 16, Iss C, Pp 107-109 (2018)
Urology Case Reports, Vol 16, Iss C, Pp 107-109 (2018)